Detailed Information

Cited 0 time in webofscience Cited 31 time in scopus
Metadata Downloads

Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment

Authors
Ye, Byoung SeokJang, Eun YoungKim, Seong YoonKim, Eun-JooPark, Sun AhLee, YunhwanHong, Chang HyungChoi, Seong HyeYoon, BoraYoon, Soo JinNa, Hae RiLee, Jae-HongJeong, Jee H.Kim, Hee JinNa, Duk L.Seo, Sang Won
Issue Date
2016
Publisher
IOS Press
Keywords
Alzheimer's disease; amnestic mild cognitive impairment; body mass index; dementia; progression
Citation
Journal of Alzheimer's Disease, v.49, no.2, pp 483 - 491
Pages
9
Journal Title
Journal of Alzheimer's Disease
Volume
49
Number
2
Start Page
483
End Page
491
URI
https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/9957
DOI
10.3233/JAD-150556
ISSN
1387-2877
1875-8908
Abstract
Background and Objective: We investigated the influence of body mass index (BMI) status at baseline and changes in BMI over a follow-up period on the development of dementia in amnestic mild cognitive impairment (aMCI) patients. Methods: The longitudinal data of 747 aMCI patients were used to investigate the relationships among baseline BMI status, subsequent changes in BMI (median follow-up duration: 1.6 years, interquartile range: 1.0-2.3 years), and risk of progression to probable Alzheimer's disease dementia (pADD). The aMCI patients were classified into underweight, normal weight, overweight, and obese subgroups, and further categorized into increased BMI, stable BMI, and decreased BMI subgroups during follow-up using a 4% mean annual change in BMI cut-off value. Results: Compared to the normal weight group, the underweight group had a higher risk of pADD (hazard ratio [HR]: 1.89, 95% confidence interval [CI]: 1.07-3.37) while the obese group had a lower risk (HR: 0.70, 95% CI: 0.49-0.999). After controlling for baseline BMI status, the decreased BMI (HR: 2.29, 95% CI: 1.41-3.72) and increased BMI (HR: 3.96, 95% CI: 2.62-6.00) groups were at increased risk of progression to pADD. Conclusions: Our findings suggested that underweight at baseline was associated with a higher risk of progression to pADD, while obesity at baseline predicted a lower risk. Furthermore, significant changes in BMI during the follow-up period reflected an increased risk of progression to pADD, regardless of BMI status at baseline.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Neurology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE